A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris

Status:
Withdrawn

Trial end date:
2020-11-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety and tolerability of parsaclisib in participants with mild to moderate pemphigus vulgaris.

Phase 2

Incyte Corporation